Objectives

At the conclusion of this session, participants will be able to:

• Discuss the place of SGLT2i and GLP-1 RA in the treatment of type 2 diabetes as per national and international guidelines
• Implement strategies to offer thesetherapies without significantly increasingthe cost to society
• Further reduce the cost of therapy bypromoting the judicious use of capillaryglucose strips